Trial Details
TERMINATEDBasic Information
| Clinical ID | c1254 |
|---|---|
| Identifier | NCT04277546 |
| Trial Title | Open-label Extension Study of Brazikumab in Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Brazikumab Maintenance Dose|DRUG: Brazikumab Induction Dose |
Participant Information
| Sponsor | AstraZeneca |
|---|---|
| City | Chula Vista |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2020-03-03 |
|---|---|
| Primary Completion Date | 2023-10-10 |
| Completion Date | 2023-10-10 |